ڕووتینی حەمام و پرۆتۆکۆلی شێدارکردن لە ئیکزیمادا

سەرچاوە زانستیەکان

1. Palmer CN et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38(4):441–446.
2. Byrd AL et al. The human skin microbiome. Nat Rev Microbiol. 2018;16(3):143–155.
3. Eichenfield LF et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338–351.
4. van Zuuren EJ et al. Emollients and moisturisers for eczema. Cochrane Database Syst Rev. 2017;2:CD012119.
5. Janmohamed SR et al. The proactive wet-wrap method with diluted corticosteroids versus emollients in children with atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol. 2014;70(6):1013–1021.
6. Meckfessel MH ve Hanifin J. The structure, function, and importance of ceramides in skin and their use as therapeutic agents in skin-care products. J Am Acad Dermatol. 2014;71(1):177–184.
7. Wollenberg A et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657–682.
8. Thomas KS et al. Randomised controlled trial of strategies to improve adherence to emollient therapy in childhood eczema. BMJ Open. 2011;1(2):e000461.